JACOBS LEVY EQUITY MANAGEMENT, INC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,169,054
+$2,864,728 QoQ
Shares Held
141,968
+72.6% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#63
of 328 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. HRMY ranks #26 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in HRMY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,169,054 | 141,968 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,304,326 | 82,268 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,078,468 | 82,268 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,608,116 | 239,772 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $8,267,381 | 261,626 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,981,029 | 300,724 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,770,777 | 313,013 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,979,240 | 224,481 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,401,485 | 245,326 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,969,440 | 237,327 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,711,140 | 238,735 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,697,279 | 234,888 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $10,065,184 | 286,024 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,289,002 | 376,386 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $20,884,387 | 379,027 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $18,653,397 | 421,165 | Shares | Sole | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||